Wegovy isn't right for everyone. Here's who shouldn't take it, what needs extra caution, and what to flag before you start.
Wegovy is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, and needs extra caution around pancreatitis, gallbladder disease, kidney problems, and planned surgery.
Per Wegovy (semaglutide) full prescribing information, Novo Nordisk. Not medical advice — share your full medical history with your prescriber before starting.
Wegovy hasn't been studied in people with a prior episode of pancreatitis — flag this with your prescriber.
Rapid weight loss itself can increase gallbladder problem risk, separate from the drug.
If you have type 2 diabetes and existing retinopathy, rapid blood sugar improvement can temporarily worsen it — needs monitoring.
GI side effects that cause dehydration can worsen kidney function — report persistent vomiting or diarrhea.
Monitor for new or worsening mood changes and report them to your prescriber.
Delayed stomach emptying raises aspiration risk under anesthesia — tell your surgical team you're on Wegovy.
One email at launch · free trial · no credit card